Invasive infections caused by Haemophilus influenzae type b after the institution of the conjugated vaccine on the expanded programm on immunization in Chile;Infecciones invasoras por Haemophilus influenzae tipo b después de la incorporación de la vacuna conjugada al programa ampliado de inmunizaciones en Chile

Revista Chilena de Infectologia

Volumn 23, Issue 1, 2006, Pages 50-54

  Cruces R , Pablo ^c   Donoso F , Alejandro ^a   Camacho A , Jorge ^a   Llorente H , Marcela ^b  

^a HOSPITAL PADRE HURTADO   (Chile)

^b Inmunología Infantil ^*

^c UNIVERSIDAD DEL DESARROLLO   (Chile)

Author keywords

Haemophilus influenzae type b; Meningitis; Pediatrics; Pneumonia; Vaccine failure

Indexed keywords

HAEMOPHILUS VACCINE; VACCINE;

ARTICLE; BACTERIAL INFECTION; CHILE; FEMALE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; IMMUNOLOGY; INCIDENCE; INFANT; MALE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; VACCINATION; VIROLOGY;

CHILD, PRESCHOOL; CHILE; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; MALE; RETROSPECTIVE STUDIES; VACCINATION; VACCINES, CONJUGATE;

EID: 33645824955     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ferreccio C, Ortiz E, Astroza L, Rivera C, Clemens J, Levine M M. A population-based retrospective assessment of the disease burden resulting from invasive Haemophilus influenzae in infants and young children in Santiago, Chile. Pediatr Infect Dis J 1990; 9: 488-94.
2. Steinhoff M C. Haemophilus influenzae type b infections are preventable everywhere. Lancet 1997; 339: 1186-7.
3. Centers for Diseases Control. Progress toward eliminating Haemophilus influenzae type b disease among infants and children - United States, 1987-97. MMWR Morb Mortal Wkly Rep 1998; 47: 993-8.
4. Lagos R, Horwitz I, Toro J, San Martín O, Abrego P, Bustamante C, et al. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J 1996; 15: 216-22.
5. Watt J P, Levine O S, Santosham M. Global reduction of Hib disease: what are the next steps? Proceedings of the Meeting Scottsdale, Arizona, September 22-25, 2002. J Pediatr 2003; 143: S163-87.
6. Sazawal S, Black R E. Pneumonia Case Management Trials Group. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis 2003; 3: 547-56.
7. Takala A K, Santosham M, Almeido-Hill J, Wolff M, Newcomer W, Reid R, et al. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J 1993; 12: 593-9.
8. Galil K, Singleton R, Levine O S, Fitzgerald M A, Bulkow L, Getty M, et al. Re-emergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis 1999; 179: 101-6.
9. Smith-Vaughan H C, Sriprakash K S, Leach A J, Mathews J D, Kemp D J. Low genetic diversity of Haemophilus influenzae type b compared to non-encapsulated H. influenzae in a population in which H. influenzae is highly endemic. Infect Immun 1998; 66: 3403-9.
10. Garner D, Weston V. Effectiveness of vaccination for Haemophilus influenzae type b. Lancet 2003; 361: 395-6.
11. Heath P T, Booy R, Griffiths H, Clutterbuck E, Azzopardi H J, Slack M P, et al. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis 2000; 31: 973-80.
12. Booy R, Heath P T, Slack M P, Begg N, Moxon E R. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet 1997; 349: 1197-202.
13. Breukels M A, Spanjaard L, Sanders L A, Rijkers G T. Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants. Clin Infect Dis 2001; 32: 1700-5.
14. Breukels M A, Jol-Van Der Zijde E, Van Tol M J, Rijkers G T. Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed. Clin Infect Dis 2002; 34: 191-7.
15. Heath P T, Mcvernon J. The UK Hib vaccine experience. Arch Dis Child 2002; 86: 396-9.
16. Kayhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983; 147: 1100.
17. Johnson P D, Hanlon M, Isaacs D, Gilbert G L. Differing antibody responses to Haemophilus influenzae type b after meningitis or epiglotitis. Epidemiol Infect 1996; 116: 21-6.
18. Holmes S J, Granoff D M. The biology of Haemophilus influenzae type b vaccination failure. J Infect Dis 1992; 154: 5121-8.
19. Kwiatkawski D. Susceptibility to infection. Br Med J 2000; 321; 1061-5.
20. Villó N, Blanco J E, Sevilla P, Vegas E, García M, Alvarez J, et al. Enfermedad invasiva por Streptococcus pneumoniae y Haemophilus influenzae serotipo b. Estudio retrospectivo de 12 años. An Pediatr (Barc) 2004; 61: 150-5.